Figure 5: Conolidine is antinociceptive in visceral, tonic and persistent suffering types and it is existing at micromolar stages within the brain soon after systemic injection. Furthermore, the conolidine molecule didn't connect with the classical receptors, indicating that it wouldn't compete from opioid peptides to bind to those receptors. https://nathaniell369wiy3.wikissl.com/user